CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +132,293 | 132,293 | ||
| 2024-10-01 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +134,430 | 134,430 | ||
| 2024-10-01 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +105,151 | 105,151 | ||
| 2024-10-01 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +89,549 | 89,549 | ||
| 2024-09-26 | KENYON LAWRENCE A Chief Financial Officer | Purchase | +5,000 | $5.69 | $28K | 5,946 |
| 2024-04-15 | Syntone Ventures LLC 10% owner | Purchase | +714,286 | 1,705,438 | ||
| 2024-04-15 | Syntone Ventures LLC 10% owner | Purchase · Warrant (Right to Buy) | +1,071,429 | 1,071,429 | ||
| 2024-03-28 | Haddadin Yezan Munther Director | Purchase | +1,881.71 | $11.82 | $22K | 5,048.71 |
| 2024-03-20 | Evanson Jeff CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-03-20 | KENYON LAWRENCE A CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-20 | TRENARY C RUSSELL III CEO AND PRESIDENT | Grant or award · Stock Option (Right to Buy) | +455,000 | 455,000 | ||
| 2024-03-18 | Sukhtian Ghiath M. Director | Grant or award | +2,305,714 | 5,808,074 | ||
| 2024-03-18 | Sukhtian Ghiath M. Director | Grant or award · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2024-03-07 | Evanson Jeff CHIEF COMMERCIAL OFFICER | Purchase | +62,484 | $0.42 | $26K | 808,459 |
| 2024-03-07 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 |
Page 4 of 8 · 142 trades